Bioengineering (Basel)
January 2020
Recombinant production of pharmaceutical proteins like antigen binding fragments (Fabs) in the commonly-used production host presents several challenges. The predominantly-used plasmid-based expression systems exhibit the drawback of either excessive plasmid amplification or plasmid loss over prolonged cultivations. To improve production, efforts are made to establish plasmid-free expression, ensuring more stable process conditions.
View Article and Find Full Text PDF